ALCAM and cancer: This study contributes to the broader field of oral squamous cell carcinoma (OSCC) research by providing novel insights into the expression patterns of putative cancer stem cell markers (CD44, CD133, and CD166) in tumor tissues, and their associations with tumor invasiveness and clinical parameters such as salivary flow rates.